Table I.
Timeline of failed therapies secondary to poor response or complication before dupilumab
Date of therapy | Therapy |
---|---|
Before 7/18/16 | Methotrexate, cyclosporine, tofacitinib, topical corticosteroids |
7/18/2016–7/26/2016 | Cyclosporine |
Before first appointment–11/22/2016 | Prednisone |
7/26/2016–8/30/2016 | Adalimumab |
8/16/2016–9/15/2016 | Ustekinumab |
8/30/2016–9/15/2016 | Apremilast |
10/11/2016–4/5/2017∗ | Secukinumab |
Secukinumab was discontinued and dupilumab was initiated 4/5/2017.